The FDA has granted the ProSense Cryoablation System marketing authorization for small, low-risk breast cancers in women at least 70 years of age who receive adjuvant endocrine therapy. The ...
IceCure Medical Ltd. announced that the FDA has granted marketing authorization for its ProSense cryoablation system for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback